Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PeptiControl is a **plant-based ingredient** developed for supplementation in individuals with elevated fasting blood glucose, pre-diabetes, or overweight. It is offered as an oral dose and is being clinically evaluated for **safety, tolerability, and effects on glucose metabolism, insulin sensitivity, and appetite regulation**. Unlike typical pharmaceuticals, PeptiControl is a bioactive peptide ingredient derived from plants, aiming to support blood glucose management through modulation of metabolic pathways. It is currently investigated in a randomized, double-blind, placebo-controlled trial for its effects on multiple endpoints such as time in glucose range (via continuous glucose monitoring), cognition, memory, and satiety, with administration 30 minutes before a meal[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PeptiControl.